CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
April 07 2021 - 8:30AM
CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused
on developing and commercializing therapeutic products for the
prevention and treatment of infectious and inflammatory disease,
today announced that CorMedix management will present a corporate
overview at the 20th Annual Needham Virtual Healthcare Conference
taking place on April 12 – 15, 2021.
20th Annual Needham Virtual Healthcare Conference
(virtual)Date: Wednesday,
April
14thTime: 4:30
pm Eastern TimeWebcast:
https://wsw.com/webcast/needham107/crmd/2235068
About CorMedixCorMedix Inc. is
a biopharmaceutical company focused on developing and
commercializing therapeutic products for the prevention and
treatment of infectious and inflammatory diseases. The Company is
focused on developing its lead product DefenCath™, a novel,
antibacterial and antifungal solution designed to prevent costly
and life-threatening bloodstream infections associated with the use
of central venous catheters in patients undergoing chronic
hemodialysis. DefenCath has been designated by FDA as Fast Track
and as a Qualified Infectious Disease Product, which provides an
additional five years of marketing exclusivity, which will be added
to the five years granted to a New Chemical Entity upon approval of
the NDA. CorMedix also intends to develop DefenCath as a catheter
lock solution for use in oncology and total parenteral nutrition
patients. It is leveraging its taurolidine technology to develop a
pipeline of antimicrobial medical devices, with programs in
surgical sutures and meshes, and topical hydrogels. The Company is
also working with top-tier researchers to develop taurolidine-based
therapies for rare pediatric cancers. Neutrolin® is CE Marked and
marketed in Europe and other territories as a medical device. For
more information, visit: www.cormedix.com.
Investor Contact:Dan FerryManaging
DirectorLifeSci Advisors617-430-7576
CorMedix (NASDAQ:CRMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
CorMedix (NASDAQ:CRMD)
Historical Stock Chart
From Sep 2023 to Sep 2024